SEER Stock Price, Seer, Inc. Quote, Chart

Market Summary

USD2.120.00

Market Closed

0.00%

SEER Stock Price

View Fullscreen

SEER RSI Chart

SEER Valuation

Market Cap

136.9M

Price/Earnings (Trailing)

-1.65

Price/Sales (Trailing)

8.74

Price/Free Cashflow

-2.36

SEER Price/Sales (Trailing)

SEER Profitability

Operating Margin

49.76%

Return on Equity

-21.64%

Return on Assets

-19.67%

Free Cashflow Yield

-42.46%

SEER Fundamentals

SEER Revenue

Revenue (TTM)

15.7M

Rev. Growth (Yr)

-24.35%

Rev. Growth (Qtr)

-30.91%

SEER Earnings

Earnings (TTM)

-83.0M

Earnings Growth (Yr)

13.69%

Earnings Growth (Qtr)

-16.18%

Breaking Down SEER Revenue

Last 7 days

6%

Last 30 days

25.4%

Last 90 days

28.5%

Trailing 12 Months

-41.3%

How does SEER drawdown profile look like?

SEER Financial Health

Current Ratio

25.27

SEER Investor Care

Shares Dilution (1Y)

1.33%

Diluted EPS (TTM)

-1.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	15.7M	0	0	0
2023	16.2M	16.6M	16.8M	16.7M
2022	9.9M	12.2M	14.0M	15.5M
2021	2.1M	3.6M	5.1M	6.6M
2020	0	0	0	656.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Seer, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 07, 2024	farokhzad omid	sold	-107,421	2.0323	-52,857	ceo and chair
Feb 22, 2024	horn david r.	sold	-20,024	1.5787	-12,684	president & cfo
Feb 22, 2024	kogan elona	sold	-20,024	1.5787	-12,684	chief legal officer
Feb 06, 2024	horn david r.	acquired	-	-	165,038	president & cfo
Feb 06, 2024	farokhzad omid	acquired	-	-	529,634	ceo and chair
Feb 06, 2024	kogan elona	acquired	-	-	123,153	chief legal officer
Feb 05, 2024	horn david r.	sold	-6,014	1.667	-3,608	president and cfo
Dec 04, 2023	kogan elona esq.	sold	-13,869	1.6951	-8,182	chief legal officer
Nov 02, 2023	farokhzad omid	acquired	6,070	0.04	151,764	ceo, president and chair
Aug 23, 2023	farokhzad omid	bought	97,968	2.4492	40,000	ceo, president and chair

Which funds bought or sold SEER recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.93	-7,524	11,199	-%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-56.64	-65,780	48,554	-%
May 15, 2024	CAPTRUST FINANCIAL ADVISORS	sold off	-100	-63,434	-	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	reduced	-17.71	-63,471	263,528	-%
May 15, 2024	Royal Bank of Canada	added	33.9	19,000	81,000	-%
May 15, 2024	WEXFORD CAPITAL LP	sold off	-100	-23,028	-	-%
May 15, 2024	PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	reduced	-4.14	-3,156	48,448	-%
May 15, 2024	SOFTBANK GROUP CORP.	unchanged	-	-205,415	9,757,230	0.05%
May 15, 2024	Voya Investment Management LLC	added	298	132,946	178,775	-%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	reduced	-13.13	-117,285	668,692	0.01%

Are Funds Buying or Selling SEER?

Are funds buying SEER calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SEER

No. of Funds

Unveiling Seer, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	fmr llc	-	0	SC 13G/A
Feb 14, 2024	farokhzad omid	9.9%	6,513,255	SC 13G/A
Feb 13, 2024	softbank group corp.	8.6%	5,135,383	SC 13G/A
Feb 13, 2024	vanguard group inc	4.37%	2,610,633	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 09, 2024	capital world investors	3.4%	2,056,000	SC 13G/A
Jan 24, 2024	blackrock inc.	9.7%	5,791,042	SC 13G/A
Jan 03, 2024	schindel yair chaim	6.44%	4,112,235	SC 13G/A
Dec 11, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	2.2%	1,302,700	SC 13G/A

Recent SEC filings of Seer, Inc.

View All Filings

Date Filed	Form Type	Document
May 08, 2024	10-Q	Quarterly Report
May 08, 2024	8-K	Current Report
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 10, 2024	SC 13G/A	Major Ownership Report
Mar 12, 2024	4	Insider Trading
Mar 06, 2024	S-8	Employee Benefits Plan
Mar 04, 2024	10-K	Annual Report
Feb 29, 2024	8-K	Current Report

Peers (Alternatives to Seer, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	233.93%	75.07%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Seer, Inc. News

Latest updates

Seer, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Revenue	-30.9%	3,066	4,438	4,162	4,008	4,053	4,605	3,955	3,621	3,312	3,066	2,155	1,334	835	336	72.00	71.00	177
Cost Of Revenue	-30.0%	1,705	2,437	2,006	1,727	1,985	2,310	2,010	2,012	2,068	1,633	986	586	-	-	-	-	-
Gross Profit	-32.0%	1,361	2,001	2,156	2,281	2,068	2,295	1,945	1,609	1,244	1,433	1,169	748	62.00	-	72.00	71.00	-
Operating Expenses	9.6%	26,553	24,233	28,001	30,222	29,513	27,244	27,011	25,043	25,030	21,307	19,600	17,419	16,560	13,377	8,488	6,438	6,002
S&GA Expenses	9.3%	14,288	13,068	14,769	16,074	15,039	14,614	15,447	14,172	14,298	13,092	11,855	10,484	10,333	7,955	3,726	1,902	1,780
R&D Expenses	9.9%	12,265	11,165	13,232	14,148	14,474	12,630	11,564	10,871	10,732	8,215	7,745	6,935	6,227	5,422	4,762	4,536	4,222
Income Taxes	-	-	-	-	-	-	-	-	-	-	40.00	164	-	-	-	-	-	-
Net Income	-16.2%	-20,679	-17,799	-21,088	-23,431	-23,959	-22,525	-23,980	-22,815	-23,646	-19,739	-18,385	-16,616	-16,429	-12,936	-8,229	-6,117	-5,493
Net Income Margin	-2.3%	-5.30*	-5.18*	-5.41*	-5.65*	-5.75*	-6.00*	-6.46*	-6.96*	-7.94*	-10.76*	-12.55*	-14.91*	-20.37*	-49.96*	-	-	-
Free Cashflow	6.8%	-11,210	-12,029	-18,612	-16,281	-19,452	-19,229	-16,059	-15,526	-20,231	-13,703	-11,401	-12,455	-15,710	-5,612	-6,355	-7,258	-6,137

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-3.3%	422	436	445	461	473	488	500	516	527	539	528	537	546	442
Current Assets	-1.9%	324	331	346	335	367	435	450	467	457	412	514	525	536	433
Cash Equivalents	69.0%	55.00	32.00	36.00	56.00	48.00	53.00	69.00	80.00	226	233	332	371	446	334
Inventory	29.3%	6.00	4.00	4.00	5.00	4.00	5.00	6.00	7.00	4.00	4.00	3.00	3.00	2.00	1.00
Net PPE	-4.6%	21.00	22.00	22.00	22.00	19.00	19.00	16.00	15.00	14.00	13.00	13.00	11.00	9.00	8.00
Liabilities	-2.4%	38.00	39.00	39.00	43.00	40.00	41.00	42.00	44.00	41.00	36.00	13.00	11.00	10.00	11.00
Current Liabilities	-3.0%	13.00	13.00	13.00	16.00	12.00	13.00	14.00	15.00	11.00	13.00	10.00	8.00	7.00	8.00
Shareholder's Equity	-3.4%	384	397	406	418	433	447	458	472	486	503	515	526	536	432
Retained Earnings	-6.8%	-326	-305	-288	-266	-243	-219	-197	-173	-150	-126	-106	-88.40	-71.79	-55.36
Additional Paid-In Capital	1.1%	711	703	695	687	677	668	657	648	639	630	622	614	608	487
Accumulated Depreciation	11.2%	14.00	13.00	11.00	10.00	8.00	8.00	7.00	6.00	6.00	5.00	4.00	3.00	3.00	2.00
Shares Outstanding	1.2%	65.00	64.00	64.00	64.00	64.00	62.00	63.00	62.00	62.00	62.00	61.00	61.00	60.00	59.00
Float	-	-	-	-	232	-	-	-	426	-	-	-	1,600	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Cashflow From Operations	-2.6%	-10,456	-10,190	-14,411	-15,133	-19,331	-14,256	-13,373	-14,000	-19,151	-12,369	-8,756	-10,350	-14,872	-5,485	-5,490	-4,779	-5,074
Share Based Compensation	-0.4%	7,580	7,614	8,334	9,752	8,724	8,160	9,073	8,378	8,062	6,671	6,786	6,431	6,039	4,784	1,177	808	579
Cashflow From Investing	429.5%	32,355	6,111	-5,625	22,939	14,479	-2,711	2,250	-133,177	10,920	-87,489	-31,126	-64,146	11,883	5,273	-50,102	7,319	2,952
Cashflow From Financing	-100.0%	-	182	28.00	212	30.00	2,106	169	866	752	1,269	609	-411	115,167	316,091	355	54,995	45.00
Buy Backs	-	-	-	13.00	-	-	-	-	20.00	-	-	29.00	-	-	7.00	3.00	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SEER Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 3,066	$ 4,053
Cost of revenue:
Total cost of revenue	1,705	1,985
Gross profit	1,361	2,068
Operating expenses:
Research and development	12,265	14,474
Selling, general and administrative	14,288	15,039
Total operating expenses	26,553	29,513
Loss from operations	(25,192)	(27,445)
Other income (expense):
Interest income	4,586	3,717
Other expense	(73)	(231)
Total other income	4,513	3,486
Net loss	(20,679)	(23,959)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities	(329)	1,158
Comprehensive loss	$ (21,008)	$ (22,801)
Net loss per share attributable to common shareholders, basic (in usd per share)	$ (0.32)	$ (0.38)
Net loss per share attributable to common shareholders, diluted (in usd per share)	$ (0.32)	$ (0.38)
Weighted-average common shares outstanding, basic	64,586,056	63,543,094
Weighted-average common shares outstanding, diluted	64,586,056	63,543,094
Nonrelated Party \| Product
Revenue:
Total revenue	$ 1,668	$ 2,343
Cost of revenue:
Total cost of revenue	991	1,436
Nonrelated Party \| Service
Revenue:
Total revenue	408	69
Cost of revenue:
Total cost of revenue	269	7
Nonrelated Party \| Grant and other
Revenue:
Total revenue	36	335
Cost of revenue:
Total cost of revenue	133	64
Related Party \| Product
Revenue:
Total revenue	954	1,306
Cost of revenue:
Total cost of revenue	$ 312	$ 478

SEER Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 54,398	$ 32,499
Short-term investments	254,152	283,725
Accounts receivable, net		4,831
Other receivables	1,346	1,326
Inventory	5,809	4,491
Prepaid expenses and other current assets	3,641	3,082
Total current assets	324,150	330,513
Long-term investments	50,642	56,858
Operating lease right-of-use assets	24,571	25,177
Property and equipment, net	21,175	22,193
Restricted cash	524	524
Other assets	900	1,004
Total assets	421,962	436,269
Current liabilities:
Accounts payable	2,564	1,370
Accrued expenses	7,572	9,212
Deferred revenue	269	206
Operating lease liabilities, current	2,280	2,295
Other current liabilities	145	139
Total current liabilities	12,830	13,222
Operating lease liabilities, net of current portion	25,404	25,964
Other noncurrent liabilities	173	179
Total liabilities	38,407	39,365
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of , March 31, 2024 and December 31, 2023; zero shares issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Additional paid-in capital	710,527	702,868
Accumulated other comprehensive loss	(521)	(192)
Accumulated deficit	(326,452)	(305,773)
Total stockholders’ equity	383,555	396,904
Total liabilities and stockholders’ equity	421,962	436,269
Class A common stock
Stockholders’ equity:
Common stock	1	1
Class B common stock
Stockholders’ equity:
Common stock	0	0
Nonrelated Party
Current assets:
Accounts receivable, net	3,815
Related Party
Current assets:
Accounts receivable, net	$ 989	$ 559

About Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

CEO	Dr. Omid C. Farokhzad M.D., Ph.D.
WEBSITE	https://seer.bio
INDUSTRY	Biotechnology
EMPLOYEES	164

Seer, Inc. Frequently Asked Questions

What is the ticker symbol for Seer, Inc.? What does SEER stand for in stocks?

SEER is the stock ticker symbol of Seer, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Seer, Inc. (SEER)?

As of Fri May 17 2024, market cap of Seer, Inc. is 136.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SEER stock?

You can check SEER's fair value in chart for subscribers.

What is the fair value of SEER stock?

You can check SEER's fair value in chart for subscribers. The fair value of Seer, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Seer, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SEER so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Seer, Inc. a good stock to buy?

The fair value guage provides a quick view whether SEER is over valued or under valued. Whether Seer, Inc. is cheap or expensive depends on the assumptions which impact Seer, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SEER.

What is Seer, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, SEER's PE ratio (Price to Earnings) is -1.65 and Price to Sales (PS) ratio is 8.74. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SEER PE ratio will change depending on the future growth rate expectations of investors.